In some MM cases with a lower rate of BRAF mutations, an increased activity of the Cyclin D1-Cyclin-dependent kinase 4/6 (CCDN1-CDK4/6) complex, mostly through gene amplification, has been demonstrated as contributing to MM pathogenesis [39]. The gene discussed is BRAF; the disease is Miyoshi myopathy.